Skip to content

A study for the effect of intake of ONO-SR/AST-SOYPC on cognitive functions

A study for the effect of intake of ONO-SR/AST-SOYPC on cognitive functions - A study for the effect of intake of ONO-SR/AST-SOYPC on cognitive functions

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000039671
Enrollment
100
Registered
2021-12-31
Start date
2020-03-02
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult

Interventions

Sponsors

TTC Co., Ltd
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Healthy males and females from 60 to 85 years of age (2) Subjects with self-awareness of forgetfulness or Those who are pointed out that there is forgetfulness

Exclusion criteria

Exclusion criteria: (1) Subjects who constantly use health food richly containing involvement ingredient (2) Subjects who regularly take drugs or health foods which may affect this study more than once a week (3) Subjects whose visual acuity is too low to perform test (4) Subjects whose hearing acuity is too low to perform test (5) Subjects having a disease of mental disorder, dementia, cranial nerve disease, or cerebrovascular disease. (6) Subjects with current menopausal disorders (7) Subjects taking drugs that may affect the results of the study (8) Subjects having a disease requiring treatment or a history of serious diseases for which medication was required (9) Subjects having a drug dependence, alcohol dependence requiring treatment or a history of serious alcohol dependence (10) Subjects suspected of having dementia based on cognitive function tests and physician interviews. (11) Subjects who may experience irregularities in their lives more than once during the study period due to night shifts, etc. (12) Subjects who are current smokers or have started smoking cessation within 12 months before the pre-treatment test. (13) Subjects who have performed the cognitive tests within 12 months prior to the pre-treatment test. (14) Subjects who donated or transfused 200 mL or 400 mL of whole blood within 3 months before the pre-treatment test. (15) Subjects who have participated in other clinical study within the last one month prior to the current study or are planned to participate in other clinical study after informed consent for the current study. (16) Subjects who are judged as unsuitable for the study based on the results of clinical and physical examination on the pre-treatment test. (17) Subjects at risk of developing allergy in relation to the study. (18) Subjects who are judged as unsuitable for the study based on the results of lifestyle questionnaire (19) Subjects judged as unsuitable for the study by the investigator for other reasons.

Design outcomes

Primary

MeasureTime frame
Tests for cognitive functions

Countries

Japan

Contacts

Public ContactTakashi Nakagawa

TTC Co., Ltd. Clinical Research Planning Department

t.nakagawa@ttc-tokyo.co.jp03-5459-5329

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026